secwatch.observer — SEC 8-K summary
======================================

Issuer:     AMARIN CORP PLCUK (AMRN)
CIK:        0000897448
Form:       8-K
Filed at:   2023-03-01T23:59:59+00:00
Accession:  0000950170-23-005329
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Amarin Q4 2022 net income $0.9M; revenue down 38% YoY; positive free cash flow $4M
--------------------------------------------------------------------------------

- Q4 2022 net product revenue $89.5M, down 38% YoY; U.S. revenue stabilized at $88.0M vs $87.9M in Q3.
- GAAP net income $0.9M ($0.00 EPS); non-GAAP adjusted net income $7.3M ($0.02 EPS).
- Positive free cash flow of $4M in Q4; cost savings program on track to exceed $100M target.
- European expansion: VAZKEPA launched in 5 markets, pricing negotiations in 5 more; peak revenue potential $1B+ in Europe.
- International: 6 regulatory approvals in 2022, plus New Zealand in Jan 2023; license agreement with CSL Seqirus for Australia/NZ.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/897448/000095017023005329/0000950170-23-005329-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/897448/000095017023005329/amrn-20230301.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-005329

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer